Clearsight Advises ECG On Its Majority Equity Recapitalization By Gryphon Investors

Clearsight Advisors is pleased to announce another highly successful transaction in the Healthcare Management Consulting Sector. Clearsight served as the exclusive strategic and financial advisor to ECG Management Consultants, Inc. in its recapitalization by Gryphon Investors.

ECG Management Consultants, Inc. (“ECG”), a Seattle-based healthcare consulting firm, has completed a recapitalization with financial partner Gryphon Investors (“Gryphon”), a San Francisco-based middle-market private equity firm. Following multiple years of outstanding financial performance and increased demand for its services, ECG is preparing for rapid growth including additional service lines, geographic expansion, and possible acquisitions. The ECG management team and employees have retained a significant ownership position in the company, and management will continue to lead ECG. Terms of the deal were not disclosed.

ECG is a leading management consulting firm providing highly specialized consulting services in the areas of strategy, finance, technology, and operations. Since its founding more than 40 years ago, ECG has consulted with more than 1,900 hospitals, health systems, academic medical centers, and medical groups across the country.

Steve Messinger President of ECG Management Consultants, Inc. said, “The Clearsight team added a lot of value through their knowledge of the market, assistance throughout the process, and, most importantly, ensuring that our objectives were well understood and the cornerstone of our arrangement.”

“We were pleased to have the opportunity to work with and represent the ECG Board and Shareholders in the this very important milestone.  The ECG Team has created a world-class consulting firm that we are confident will continue to lead and shape the Healthcare Industry,” stated Joel Kallett, Co-Founder and Managing Director of Clearsight Advisors.